As reported by Kaiser Health News: The value of drugmakers’ copay cards has become more unpredictable as insurers try to restrict their use. Many insurance plans, for instance, do not count the money from a copay program toward a patient’s deductible.And patients who use a copay card can wind up paying full or nearly full price…
Is a private-label product really better once you factor in performance, durability, and everything it takes to support it? Sometimes yes and sometimes no. The job is knowing the difference. The post Maximizing Value vs. Minimizing Cost in Healthcare Purchasing appeared first on MedCity News.
The startup’s first disease target is chronic inflammatory demyelinating polyneuropathy (CIDP), which can be treated with a blockbuster Argenx drug. Nuvig aims to show its drug can offer a better way to treat this disease and other autoimmune conditions. The post Nuvig Therapeutics Nabs $161M to Build Case for a Better Approach to Autoimmune Disease…
Health and Human Services Secretary Robert F. Kennedy Jr.’s testimony before the Senate Finance Committee follows the ouster last week of the director of the Centers for Disease Control and Prevention, Susan Monarez. At least four other senior CDC officials resigned in protest. What are the biggest takeaways? What comes next? Tune in for a…
WINSTON-SALEM, N.C. — Some issues, like immigration or student loans, are too divisive to unite Trinity Moravian Church. “We’ve got quite a spread of political beliefs,” said the Rev. John Jackman, who leads this 114-year-old red-brick church near Winston-Salem’s old textile mills. Conservative Republicans sit with liberal Democrats. Supporters of President Donald Trump mix with…
KFF Health News editor-at-large for public health Céline Gounder discussed bird flu on CBS’ “CBS Mornings Plus” on March 20. Gounder discussed funding cuts at Johns Hopkins University and other research institutions on CBS News’ “CBS Morning News” on March 17. She also discussed the Centers for Disease Control and Prevention’s airplane wastewater testing to…
Engage Bio developed a platform technology that enables non-viral delivery of DNA to cells. The acquisition is the latest in a series of Eli Lilly deals that expand the pharmaceutical company’s pipeline and capabilities in genetic medicines. The post Eli Lilly Grows Again in Genetic Medicines, Buying Startup With a New Way to Deliver DNA…
Regeneron Pharmaceuticals said the FDA cited no approvability concerns for its multiple myeloma drug, linvoseltamab, other than previously identified issues with a contract manufacturer. While linvoseltamab trails bispecific antibodies currently marketed by Johnson & Johnson and Pfizer, if approved, it could bring patients an earlier treatment option. The post FDA Rejection Delays Regeneron From Competing…
It’s critical that healthcare organizations delivering on the program’s promise not be torpedoed by the “bad actors” The post The Case for 340B Done Right appeared first on MedCity News.
El médico de familia Eric Boose ha estado usando una herramienta de inteligencia artificial (IA) para volver a lo que él llama la “medicina a la antigua”: hablar con los pacientes cara a cara, sin tener que escribir en una computadora al mismo tiempo. “Realmente puedo sentarme, interactuar, concentrarme en ellos y escuchar”, dijo Boose,…